Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.93% | -7.14% | 2.79% | 7.33% | 6.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.93% | -7.14% | 2.79% | 7.33% | 6.13% |
| Cost of Revenue | 5.59% | -17.68% | -13.84% | -1.00% | 16.02% |
| Gross Profit | 0.78% | -4.18% | 8.03% | 12.60% | 3.39% |
| SG&A Expenses | 6.08% | 0.71% | 2.61% | 5.63% | -1.00% |
| Depreciation & Amortization | 22.09% | 18.88% | 23.25% | 46.61% | 42.78% |
| Other Operating Expenses | 27.71% | 22.42% | 25.83% | 20.19% | -11.43% |
| Total Operating Expenses | 8.89% | -5.69% | -5.32% | 4.50% | 5.81% |
| Operating Income | -16.14% | -12.64% | 27.41% | 13.11% | 6.99% |
| Income Before Tax | 21.37% | -119.21% | 23.57% | 6.48% | -33.05% |
| Income Tax Expenses | -17.68% | -128.63% | 45.28% | -5.13% | -0.98% |
| Earnings from Continuing Operations | 32.85% | -118.34% | 20.08% | 8.77% | -38.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.85% | -118.34% | 20.08% | 8.77% | -38.87% |
| EBIT | -16.14% | -12.64% | 27.41% | 13.11% | 6.99% |
| EBITDA | -10.23% | -6.98% | 23.54% | 14.61% | 10.24% |
| EPS Basic | 31.86% | -118.21% | 19.34% | 8.11% | -39.24% |
| Normalized Basic EPS | -18.65% | -10.63% | 33.47% | 13.42% | 12.91% |
| EPS Diluted | 31.10% | -118.30% | 19.17% | 8.25% | -39.26% |
| Normalized Diluted EPS | -19.04% | -10.39% | 33.39% | 13.50% | 13.07% |
| Average Basic Shares Outstanding | 0.75% | 0.69% | 0.62% | 0.62% | 0.62% |
| Average Diluted Shares Outstanding | 1.23% | 0.41% | 0.68% | 0.55% | 0.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |